|







| |
Omega 3 and Omega 6 Pathways - Inflammation and Asthma
(back to EFA)
Drug VS Non-drug approaches to inflammation
To understand why inflammation is increased in asthma, how asthma
drugs work, and why the RAINS Study approach may be effective, it is necessary to go into
a little chemistry. We have tried to take a simple step-by-step approach for those who are
new to the subject.
The principle difference between our
complementary approach, and a strictly drug approach, lies in the importance
of providing sufficient nutrients for the body to properly reduce
inflammation. The nutrients necessary, just for the following pathways to
function properly are:
- essential fatty acids (omega-3 and omega-6, in
balance),
- zinc,
- magnesium,
- pyroxidine (vitamin B6),
- niacin (vitamin B3), and
- ascorbic acid (vitamin C).
Deficiencies in any one of these nutrients can lead to excess
inflammation and result in an increase in asthma symptoms.
Omega-3 and Omega-6 Pathways
If you have a chemistry background, the following explanation may be
old hat to you.
Conversely, however, if this is your first look at omega-3 and
omega-6 metabolism, at first glance, the following figures and explanations may seem a
little complicated.
By taking your time, in the next few minutes you will learn,
step-by-step:
- The composition of fatty acids,
- How omega-3 fats can reduce inflammation in asthma,
- How too much of omega-6 fats and/or too little of omega-3 fats, can
create inflammation,
- How enzymes are responsible for the conversion of fats,
- How nutritional deficiencies can indirectly create inflammation in
asthma,
- Why omega-3/omega-6 balance in the body is important for
asthmatics
BEFORE YOU START - A tip to make this lesson
easier for you - Keep the line you're reading scrolled to the top of the page. Try it, and
scroll up until this is the line is at the top of the page now, and don't forget to keep
scrolling as you read each line.
|
Omega-3 fatty acid Family
and the
Prostaglandin 3 (PGE3) Pathway
|
Fatty acids are made up of "chains" of the elements CARBON,
OXYGEN AND HYDROGEN.
These fatty acid chains can be changed or converted into different
patterns.
These changes happen as a result of fatty acids interacting with
enzymes.
Enzymes have the ability then, to change fatty acids.
Omega-3 metabolism is the result of enzymes
converting fatty acids to their various forms - their derivatives.
The enzymes will
either:
1. Lengthen the fatty acid carbon chain (elongate it -
make it longer), by adding carbon atoms, or
2. Insert more double bonds into the carbon chain
while at the same time, removing hydrogen atoms (desaturate it).
Let's look at an example.
As shown in the figure below, the fatty
acid - alpha-linolenic acid is changed to stearidonic acid by the enzyme delta-6-desaturase. (Please don't be scared of these big
names for little fats and enzymes!)
Let me explain the formula of
Alpha linolenic acid - 18:3w3.
The
18 stands for the number of carbon
atoms in the alpha-linolenic acid chain.
The first
3 stands for the total number of
double bonds, between carbon atoms, in the carbon chain.
The "w3"
stands for place the first double bond occurs in the carbon chain. (3
carbon atoms from the left end of the chain in the figure below) Isn't chemistry fun?
|


As you can see, in the above figure,
the newly formed Stearidonic Acid, has had an extra double bond created
in the carbon chain.
The number of carbon atoms (18) hasn't changed.
However, the number of hydrogen atoms has been reduced from 29 to 27. Another way of
looking at it, is that the carbon chain is now less saturated with hydrogen atoms. In
other words the chain has been de-saturated
of two hydrogen atoms.
In this example the "desaturation"
of hydrogen atoms that has happened is the result of the enzyme delta-6-desaturase. Can you now see how this enzyme gets the desaturase part of it's name?
Now, can you guess what saturated
fat means?
That's right, a carbon chain that is
completely full of hydrogen atoms, with no spaces for any more hydrogen atoms.
These saturated fatty acid chains can vary from 3-20 carbon atoms.
If a fat is "hydrogenated",
in a manufacturing process, what do you think they've done? If you guessed that they
filled up the fat with hydrogen atoms, you're right.
You can probably now guess what partially-hydrogenated fat means.
So, what does hydrogenation of fat mean to you?
Well, the more empty spaces there are in a fatty acid
chain, the more biologically active and alive these fats are.
Saturated fats on the other hand are
biologically inactive, which means for all our purposes, they are dead.
That's why you can leave saturated fat
products on the shelf
without them "going bad" or rancid. When you're a dead fat, there's no
"going bad."
We have been sold on the idea of using dead,
hydrogenated, saturated fats because they have a long, economical, shelf life.
Live, unsaturated fatty acids on the other hand do
"go bad" or rancid after awhile.
This is actually good news, because these are the kind
of fats you want in your diet.
Live fats. And, which do you think your living cells prefer
- live or dead fats?
In the next few slides, you'll now see how the
enzymes delta-6-desaturase,
delta-5-desaturase, elongase, cyclo-oxygenase and
oxygenase alter the structure of alpha-linolenic acid (omega-3) into
the
beneficial, anti-inflammatory prostaglandins PGE3 series
prostaglandins - which reduce inflammation in the body. (Don't worry, we'll take you through, step-by-step as you scroll
down).
The following figure shows the conversion pathway of
alpha-linolenic acid (1). Note the nutrients that are essential to the
enzymes, which make the conversions possible. Without enough of these nutrients these
conversions cannot happen. The consequences of this will become clear in a few moments.
Alpha-linolenic acid (1) is converted into stearidonic
acid (4) by the enzyme delta-6-desaturase (2). Delta-6-desaturase requires
sufficient B6, magnesium and zinc(3) to perform it's duties.
Stearidonic acid (4) is then converted to
eicosatetraenoic acid (6) by the enzyme elongase (5).(scroll down)

Eicosatetraenoic acid (6) is then converted to eicosapentaenoic acid
(EPA)(9) by the enzyme delta-5-desaturase. Delta-5-desaturase is dependent upon
the nutrients vitamin C, niacin and zinc to properly perform
it's functions. Unfortunately asthmatics have been shown to be deficient in each of these
three nutrients. (See Vitamin
C & B3 Deficiencies and Zinc Deficiencies)
Delta-5-desaturase also prefers to convert EPA into
anti-inflammatory prostaglandins of the PGE3 series. This is good news for asthmatics, as
this would help to reduce inflammation.
The following figure illustrates that conversion of EPA (9) into
anti-inflammatory prostaglandins of the PGE3 series by way of (10) cyclo-oxygenase
(COX).
Cyclo-oxygenase and oxygenase
conversion of EPA

Unfortunately, the use of COX
inhibitors blocks this conversion, and therefore blocks the benefit to the cells of the
PGE3 series anti-inflammatory prostaglandins (11). COX
inhibitors are targeted at the Omega 6 pathway, which we will now
look at.
| The Omega-6
Family and |
|
| Prostaglandin 1 (PGE1) and |
|
| Prostaglandin 2 (PGE2) Pathways |
|
|
|
| The following figure shows the pathway of the Omega-6
(linoleic acid) fatty acid.
The first conversion is from (1) linoleic acid into (4) gamma linolenic acid. This is achieved through the action of the
delta-6-desaturase enzyme (2).
Note that the delta-6-desaturase enzyme (2) is dependent
upon sufficient quantities of vitamin B6, magnesium and zinc (3).
Deficiencies in any of these three nutrients can impair the
conversion. Unfortunately, asthmatics have been shown to have deficiencies in all three.
Next is the conversion of gamma linolenic acid (4) into dihomogamma
linolenic acid (6) by the enzyme elongase (5). |
|

| Dihomogamma linolenic acid
(4) is now converted by
delta-5-desaturase to either Arachidonic Acid (AA)(11) or Series 1 Prostaglandins (8).
As you can see, the preferred pathway(7)
for omega-6 fatty acids is to the Series 1, anti-inflammatory prostaglandins
(8) PGE1.
PGE1 relaxes blood vessels, improving circulation, lowering blood
pressure, and even relieving angina. It decreases inflammation response, helping to
control arthritis and asthma.
It also regulates calcium metabolism which is helpful in
asthma.
PGE1 also improves the functioning of T-cells in our immune system,
which destroy foreign molecules and cells that can aggravate asthma symptoms.
Finally, PGE1 prevents the release of inflammation causing
arachidonic acid from our cell membranes.
Now, this is important to understand:
When there is a deficiency of omega-3 fatty acids in
the diet, the delta-5-desaturase enzyme (9), rather than being used to convert EPA into
Series 3 (anti-inflammatory prostaglandins in the Omega 3
pathway), will begin to convert more DGLA
(6) into arachidonic acid (11) and the inflammatory Series 2 Prostaglandins
(13).
COX-2 enzyme inhibitors reduce inflammation by blocking the final step (12)
in the arachidonic acid to Series 2 Prostaglandin pathway.
This is a good news/bad news story, because
while they block the production of inflammatory prostaglandins, they also block the production of the
anti-inflammatory Series 3 Prostaglandins in the Omega-3 Pathways.
The following diagram shows where top asthma drugs
interfere with the arachadonic acid pathway:
The following is a list of some commonly prescribed NSAIDs:
| Generic Name |
Brand Name |
Traditional NSAIDS
Acetylsalicylic Acid (ASA)
Diclofenac
Ibuprofen
Naproxen |
Aspirin* Voltaren Advil, Motrin* Naprosyn,
Anaprox |
COX-2 Inhibitors
Celecoxib
Rofecoxib |
While drugs designed to interfere with the Arachadonic pathways do
give relief, they ignore potential unknown side-effects resulting from interference in
both omega-3 and omega-6 pathways.
This gives further clarity to the importance of the balance of
omega-3 to omega-6 fatty acids and the specific nutrients required in the diet for the
enzymes necessary for the proper conversions.
If essential fatty acids are properly balanced, the body is in a
state of homeostasis, leaning towards a state of non-inflammation. To the degree that
balance shifts, towards excessive omega-6 in the diet, we see an increase in inflammatory
conditions like asthma and arthritis.
To reach that homeostasis, we believe in the restoration of the
entire pathways through sufficient essential fatty acid intake, of both omega-3 and
omega-6, and enzyme support provided through supplementation of nutrients to make up for
any existing deficiencies.
Inflammatory conditions, due to imbalanced ratios
of essential fatty acids, are presented in a number of other studies.
|
|
|
|
|